- Report
- August 2022
- 100 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- September 2022
- 112 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- September 2022
- 225 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- August 2022
- 135 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- August 2020
- 80 Pages
Global
From €2650EUR$2,750USD£2,279GBP
- Report
- May 2020
- 200 Pages
Global
From €6697EUR$6,950USD£5,761GBP
- Report
- August 2022
- 117 Pages
Global
From €4336EUR$4,500USD£3,730GBP
- Report
- October 2021
- 100 Pages
Global
From €4336EUR$4,500USD£3,730GBP
- Report
- January 2023
- 50 Pages
China
From €2891EUR$3,000USD£2,487GBP
- Report
- July 2018
- 30 Pages
China
From €2120EUR$2,200USD£1,824GBP
- Report
- April 2020
- 125 Pages
Global
From €3527EUR$3,660USD£3,034GBP
- Report
- May 2023
- 171 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- June 2021
- 239 Pages
Global
From €3469EUR$3,600USD£2,984GBP
- Report
- June 2021
- 84 Pages
North America
From €1445EUR$1,500USD£1,243GBP
- Report
- June 2021
- 93 Pages
Africa, Middle East
From €1445EUR$1,500USD£1,243GBP
- Report
- June 2021
- 94 Pages
Europe
From €1445EUR$1,500USD£1,243GBP
- Report
- June 2021
- 94 Pages
Asia Pacific
From €1445EUR$1,500USD£1,243GBP
- Drug Pipelines
- September 2020
- 35 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- August 2020
- 56 Pages
Global
From €1927EUR$2,000USD£1,658GBP
Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery.
Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage.
Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases.
Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more